Viking Therapeutics, Inc.
US ˙ NasdaqCM ˙ US92686J1060

SecurityVKTX / Viking Therapeutics, Inc.
InstitutionAlps Advisors Inc
Latest Disclosed Ownership94,070 shares
Latest Disclosed Value $ 3,061,038
Alps Advisors Inc reports 1.57% increase in ownership of VKTX / Viking Therapeutics, Inc.

On May 8, 2026 - Alps Advisors Inc filed a 13F-HR form disclosing ownership of 94,070 shares of Viking Therapeutics, Inc. (US:VKTX) valued at $3,061,038 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 92,616 shares of Viking Therapeutics, Inc.. This represents a change in shares of 1.57% during the quarter. The current value of the position is $2,676,292 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F VIKING THERAPEUTICS COM 92686J106 94,070 1,454 1.57 3,061 -6.05 0.0132
2026-02-12 2025-12-31 13F VIKING THERAPEUTICS COM 92686J106 92,616 37,782 68.90 3,258 126.09 0.0190
2025-11-05 2025-09-30 13F VIKING THERAPEUTICS COM 92686J106 54,834 -5,795 -9.56 1,441 -10.27 0.0080
2025-08-11 2025-06-30 13F VIKING THERAPEUTICS COM 92686J106 60,629 60,629 1,607 0.0093
2024-08-13 2024-06-30 13F VIKING THERAPEUTICS COM 92686J106 0 -74,007 -100.00 0 -100.00
2024-05-14 2024-03-31 13F VIKING THERAPEUTICS COM 92686J106 74,007 7,630 11.49 6,069 391.34 0.0430
2024-02-14 2023-12-31 13F VIKING THERAPEUTICS COM 92686J106 66,377 -7,428 -10.06 1,235 51.16 0.0097
2023-11-14 2023-09-30 13F VIKING THERAPEUTICS COM 92686J106 73,805 418 0.57 817 -31.29 0.0068
2023-08-14 2023-06-30 13F VIKING THERAPEUTICS COM 92686J106 73,387 21,669 41.90 1,190 38.10 0.0103
2023-05-10 2023-03-31 13F VIKING THERAPEUTICS COM 92686J106 51,718 -325 -0.62 861 76.07 0.0076
2023-02-14 2022-12-31 13F VIKING THERAPEUTICS COM 92686J106 52,043 52,043 489 0.0044
2022-08-15 2022-06-30 13F/A-1 VIKING THERAPEUTICS COM 92686J106 0 -80,540 -100.00 0 -100.00
2022-08-10 2022-06-30 13F VIKING THERAPEUTICS COM 92686J106 0 -80,540 0
2022-05-16 2022-03-31 13F VIKING THERAPEUTICS COM 92686J106 80,540 -9,999 -11.04 242 -41.83 0.0026
2022-02-09 2021-12-31 13F VIKING THERAPEUTICS COM 92686J106 90,539 -5,296 -5.53 416 -30.90 0.0047
2021-11-15 2021-09-30 13F VIKING THERAPEUTICS COM 92686J106 95,835 -7,030 -6.83 602 -2.27 0.0058
2021-08-11 2021-06-30 13F VIKING THERAPEUTICS COM 92686J106 102,865 -29,113 -22.06 616 -26.23 0.0054
2021-05-07 2021-03-31 13F VIKING THERAPEUTICS COM 92686J106 131,978 469 0.36 835 12.84 0.0082
2021-02-03 2020-12-31 13F VIKING THERAPEUTICS COM 92686J106 131,509 38,719 41.73 740 37.04 0.0083
2020-11-05 2020-09-30 13F/A-1 VIKING THERAPEUTICS COM 92686J106 92,790 -6,237 -6.30 540 -24.37 0.0079
2020-11-04 2020-09-30 13F VIKING THERAPEUTICS COM 92686J106 92,790 -6,237 540 6,920.7469
2020-08-05 2020-06-30 13F VIKING THERAPEUTICS COM 92686J106 99,027 -32,351 -24.62 714 16.10 0.0096
2020-05-06 2020-03-31 13F VIKING THERAPEUTICS COM 92686J106 131,378 -15,322 -10.44 615 -47.75 0.0095
2020-02-07 2019-12-31 13F VIKING THERAPEUTICS COM 92686J106 146,700 2,681 1.86 1,177 18.77 0.0092
2019-11-04 2019-09-30 13F VIKING THERAPEUT COMMON STOCK 92686J106 144,019 -6,791 -4.50 991 -20.85 0.0077
2019-08-07 2019-06-30 13F VIKING THERAPEUT COMMON STOCK 92686J106 150,810 -21,793 -12.63 1,252 -27.04 0.0093
2019-05-01 2019-03-31 13F VIKING THERAPEUT COMMON STOCK 92686J106 172,603 7,458 4.52 1,716 35.87 0.0121
2019-02-04 2018-12-31 13F VIKING THERAPEUT COMMON STOCK 92686J106 165,145 165,145 1,263 0.0098
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.